Nantahala Capital Management, LLC

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-15
Total Holdings: 133
Total Value: 2187261798
Accession Number: 0001104659-25-049574
Form Type: 13F-HR
CIK: 0001472322
Manager Name: Nantahala Capital Management, LLC

Data Enrichment

90% identified

120 identified13 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

133 positions • $2,187,261.798K total value

133 positions

Manager:

SEC FilingSEC DataHachi Filing

Search and click to pin securities to the top

Page 3 of 7

Sort by:

Tourmaline Bio, Inc.

TRML|89157D105

532824(-0.8%)

Value:

$8.1B(-25.6%)

COMPASS Pathways plc

CMPS|20451W101

2829232(+182.9%)

Value:

$8.1B(+114.1%)

05479K106

3184947(+11.2%)

Value:

$8.1B(-24.8%)

Centessa Pharmaceuticals plc

CNTA|152309100

554803(+8.2%)

Value:

$8.0B(-7.1%)

CODEXIS, INC.

CDXS|192005106

2830619(-0.4%)

Value:

$7.6B(-43.8%)

Aura Biosciences, Inc.

AURA|05153U107

1267697(-0.2%)

Value:

$7.4B(-28.8%)

Disc Medicine, Inc.

IRON|254604101

148391(-1.1%)

Value:

$7.4B(-22.5%)

Avalo Therapeutics, Inc.

AVTX|05338F306

900000

Value:

$7.2B

PALVELLA THERAPEUTICS, INC.

PVLA|697947109

250062(+0.0%)

Value:

$7.0B(+133.2%)

Syndax Pharmaceuticals Inc

SNDX|87164F105

554503(-1.1%)

Value:

$6.8B(-8.1%)

VIEMED HEALTHCARE, INC.

VMD|92663R105

932445(-0.3%)

Value:

$6.8B(-9.5%)

ONE Group Hospitality, Inc.

STKS|88338K103

2121084(+1.6%)

Value:

$6.3B(+4.8%)

45779A846

2318017(+38.4%)

Value:

$6.2B(+41.6%)

RAPT Therapeutics, Inc.

RAPT|75382E109

5012927(+303.1%)

Value:

$6.1B(+211.3%)

Anteris Technologies Global Corp.

AVR|03675P102

1663666(-0.2%)

Value:

$5.9B(-36.0%)

Assertio Holdings, Inc.

ASRT|04546C205

8439762(+3.6%)

Value:

$5.7B(-19.8%)

Unicycive Therapeutics, Inc.

UNCY|90466Y103

9391994(-9.6%)

Value:

$5.4B(-34.6%)

Xtant Medical Holdings, Inc.

XTNT|98420P308

11394000(+0.0%)

Value:

$5.4B(+6.1%)

NEKTAR THERAPEUTICS

NKTR|640268108

7789051(-0.3%)

Value:

$5.3B(-27.1%)

Cogent Biosciences, Inc.

COGT|19240Q201

843489(-1.1%)

Value:

$5.1B(-24.0%)

Instrument	Shares		Other Manager	Value
Tourmaline Bio, Inc.(TRMLcusip89157D105)	532.8K	QoQ -0.76% (-4.1K) YoY -23.98% (-168.1K)	All Managers (Combined)	$8.1M	QoQ -25.57% (-$2.8M) YoY -49.50% (-$7.9M)
Compass Pathways Plc(CMPScusip20451W101)	2.8M	QoQ +182.92% (+1.8M) YoY NEW(+2.8M)	All Managers (Combined)	$8.1M	QoQ +114.06% (+$4.3M) YoY NEW(+$8.1M)
(cusip05479K106)✕	3.2M	QoQ +11.16% (-320.0K) YoY +93.02% (+1.5M)	All Managers (Combined)	$8.1M	QoQ -24.79% (-$2.7M) YoY +55.03% (+$2.9M)
Centessa Pharmaceuticals Plc(CNTAcusip152309100)	554.8K	QoQ +8.22% (-42.2K) YoY NEW(+554.8K)	All Managers (Combined)	$8.0M	QoQ -7.08% (-$608.8K) YoY NEW(+$8.0M)
Codexis, Inc.(CDXScusip192005106)	2.8M	QoQ -0.38% (-11.0K) YoY -36.55% (-1.6M)	All Managers (Combined)	$7.6M	QoQ -43.82% (-$5.9M) YoY -51.10% (-$8.0M)
Aura Biosciences, Inc.(AURAcusip05153U107)	1.3M	QoQ -0.18% (-2.3K) YoY -4.09% (-54.2K)	All Managers (Combined)	$7.4M	QoQ -28.84% (-$3.0M) YoY -28.40% (-$2.9M)
Disc Medicine, Inc.(IRONcusip254604101)	148.4K	QoQ -1.07% (-1.6K) YoY NEW(+148.4K)	All Managers (Combined)	$7.4M	QoQ -22.54% (-$2.1M) YoY NEW(+$7.4M)
Avalo Therapeutics, Inc.(AVTXcusip05338F306)	900.0K	QoQ NEW(+900.0K) YoY NEW(+900.0K)	All Managers (Combined)	$7.2M	QoQ NEW(+$7.2M) YoY NEW(+$7.2M)
Palvella Therapeutics, Inc.(PVLAcusip697947109)	250.1K	QoQ 0.00% (+0) YoY NEW(+250.1K)	All Managers (Combined)	$7.0M	QoQ +133.24% (+$4.0M) YoY NEW(+$7.0M)
Syndax Pharmaceuticals Inc(SNDXcusip87164F105)	554.5K	QoQ -1.07% (-6.0K) YoY +19.18% (-89.2K)	All Managers (Combined)	$6.8M	QoQ -8.07% (-$598.2K) YoY -38.48% (-$4.3M)
Viemed Healthcare, Inc.(VMDcusip92663R105)	932.4K	QoQ -0.28% (-2.7K) YoY -39.84% (-617.7K)	All Managers (Combined)	$6.8M	QoQ -9.48% (-$711.5K) YoY -53.56% (-$7.8M)
One Group Hospitality, Inc.(STKScusip88338K103)	2.1M	QoQ +1.61% (+33.7K) YoY +287.26% (+1.6M)	All Managers (Combined)	$6.3M	QoQ +4.76% (+$288.6K) YoY +107.88% (+$3.3M)
(cusip45779A846)✕	2.3M	QoQ +38.42% (+643.5K) YoY +12.17% (+251.6K)	All Managers (Combined)	$6.2M	QoQ +41.58% (+$1.8M) YoY +27.31% (+$1.3M)
Rapt Therapeutics, Inc.(RAPTcusip75382E109)	5.0M	QoQ +303.12% (+3.8M) YoY NEW(+5.0M)	All Managers (Combined)	$6.1M	QoQ +211.27% (+$4.2M) YoY NEW(+$6.1M)
Anteris Technologies Global Corp.(AVRcusip03675P102)	1.7M	QoQ -0.18% (-3.0K) YoY NEW(+1.7M)	All Managers (Combined)	$5.9M	QoQ -36.04% (-$3.4M) YoY NEW(+$5.9M)
Assertio Holdings, Inc.(ASRTcusip04546C205)	8.4M	QoQ +3.57% (-291.4K) YoY -8.96% (-831.1K)	All Managers (Combined)	$5.7M	QoQ -19.78% (-$1.4M) YoY -35.98% (-$3.2M)
Unicycive Therapeutics, Inc.(UNCYcusip90466Y103)	9.4M	QoQ -9.62% (-1.0M) YoY +181.56% (-6.1M)	All Managers (Combined)	$5.4M	QoQ -34.57% (-$2.9M) YoY -37.53% (-$3.2M)
Xtant Medical Holdings, Inc.(XTNTcusip98420P308)	11.4M	QoQ 0.00% (+0) YoY +184.85% (+7.4M)	All Managers (Combined)	$5.4M	QoQ +6.09% (+$307.6K) YoY +14.42% (+$675.2K)
Nektar Therapeutics(NKTRcusip640268108)	7.8M	QoQ -0.26% (-20.9K) YoY +214.58% (+5.3M)	All Managers (Combined)	$5.3M	QoQ -27.07% (-$2.0M) YoY +128.98% (+$3.0M)
Cogent Biosciences, Inc.(COGTcusip19240Q201)	843.5K	QoQ -1.09% (-9.4K) YoY +6.64% (-52.6K)	All Managers (Combined)	$5.1M	QoQ -24.04% (-$1.6M) YoY -4.94% (-$262.6K)